Fu Yu, Zeng Lijiao, Huang Pilai, Liao Mingfeng, Li Jialu, Zhang Mingxia, Shi Qinlang, Xia Zhaohua, Ning Xinzhong, Mo Jiu, Zhou Ziyuan, Li Zigang, Yuan Jing, Wang Lifei, He Qing, Wu Qikang, Liu Lei, Liao Yuhui, Qiao Kun
Department of Infectious Diseases, Department of Thoracic Surgery, Department of Radiology, National Clinical Research Center for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen Third People's Hospital, Shenzhen, China.
Department of Biostatistics, HuaJia Biomedical Intelligence, Shenzhen, China.
Heliyon. 2023 Jul 27;9(8):e18764. doi: 10.1016/j.heliyon.2023.e18764. eCollection 2023 Aug.
Progression to a severe condition remains a major risk factor for the COVID-19 mortality. Robust models that predict the onset of severe COVID-19 are urgently required to support sensitive decisions regarding patients and their treatments. In this study, we developed a multivariate survival model based on early-stage CT images and other physiological indicators and biomarkers using artificial-intelligence analysis to assess the risk of severe COVID-19 onset. We retrospectively enrolled 338 adult patients admitted to a hospital in China (severity rate, 31.9%; mortality rate, 0.9%). The physiological and pathological characteristics of the patients with severe and non-severe outcomes were compared. Age, body mass index, fever symptoms upon admission, coexisting hypertension, and diabetes were the risk factors for severe progression. Compared with the non-severe group, the severe group demonstrated abnormalities in biomarkers indicating organ function, inflammatory responses, blood oxygen, and coagulation function at an early stage. In addition, by integrating the intuitive CT images, the multivariable survival model showed significantly improved performance in predicting the onset of severe disease (mean time-dependent area under the curve = 0.880). Multivariate survival models based on early-stage CT images and other physiological indicators and biomarkers have shown high potential for predicting the onset of severe COVID-19.
病情进展为重症仍然是新冠病毒疾病(COVID-19)死亡的主要风险因素。迫切需要可靠的模型来预测重症COVID-19的发病,以支持针对患者及其治疗的敏感决策。在本研究中,我们基于早期CT图像以及其他生理指标和生物标志物,利用人工智能分析开发了一个多变量生存模型,以评估重症COVID-19发病的风险。我们回顾性纳入了中国一家医院收治的338例成年患者(重症率为31.9%;死亡率为0.9%)。比较了重症和非重症患者的生理和病理特征。年龄、体重指数、入院时的发热症状、并存的高血压和糖尿病是重症进展的风险因素。与非重症组相比,重症组在早期显示出提示器官功能、炎症反应、血氧和凝血功能的生物标志物异常。此外,通过整合直观的CT图像,多变量生存模型在预测重症疾病发病方面表现出显著改善的性能(平均时间依赖性曲线下面积=0.880)。基于早期CT图像以及其他生理指标和生物标志物的多变量生存模型在预测重症COVID-19发病方面显示出很高的潜力。